KARYOPHARM THERAPEUTICS INC earnings per share and revenue

25K earnings per share for the last quarter are -0.30 EUR whereas the estimation was -0.31 EUR which accounts for 4.15% surprise. Company revenue for the same period amounts to 30.70 M EUR despite the estimated figure of 31.96 M EUR. Estimated earnings per share for the next quarter are -0.29 EUR, and revenue is expected to reach 33.35 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.